Runben Biotech's IPO elevates Huangpu's count to 83 listings

Runben Biotechnology, located in Guangzhou's Huangpu district, went public on the main board of the Shanghai Stock Exchange with the stock code "603193" on Oct 17.

This listing elevates Huangpu's tally to 83 publicly traded companies, making it the region with the highest number of listings both citywide and within all national economic development zones.

Runben Biotech specializes in the research, production, and sale of personal care and mosquito repellent products. The capital raised from this IPO will mainly be used for R&D at its Huangpu factory to support industrialization endeavors, enhance channel construction and brand promotion, and facilitate information system upgrades. These initiatives are geared towards amplifying brand presence and product competitiveness to capture a larger market share.

In recent years, Huangpu has seized opportunities in the capital market. It embarked on programs to nurture businesses towards public listings, providing comprehensive support in the journey. It has also promoted industrial transformations and upgrading and spurred quality-driven growth. 

There are more than 40,000 technology-centric companies in Huangpu district, of which over 3,500 are high-tech enterprises.

Moving ahead, Huangpu will further deepen its focus on fostering listings, propel the development of emerging industries, bolster innovation and core competitiveness, and pave the way for a refreshed developmental paradigm.

Share - WeChat